An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Sellas Life Sciences Group
Pfizer
MacroGenics
Celgene
University of Wisconsin, Madison
AbbVie
Butler Hospital
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Novartis
Fox Chase Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center